Pharming Group (NASDAQ:PHAR) Shares Gap Up to $10.99
Pharming Group (NASDAQ:PHAR) Shares Gap Up to $10.99
Shares of Pharming Group (NASDAQ:PHAR – Get Rating) gapped up before the market opened on Monday . The stock had previously closed at $10.99, but opened at $11.35. Pharming Group shares last traded at $11.49, with a volume of 30 shares traded.
Analyst Ratings Changes
Separately, TheStreet raised shares of Pharming Group from a "d+" rating to a "c" rating in a research note on Monday, August 15th.
Get Pharming Group alerts:Pharming Group Stock Up 2.0 %
The business's 50 day moving average price is $10.65 and its 200-day moving average price is $9.37. The firm has a market capitalization of $763.12 million, a PE ratio of 27.95 and a beta of -0.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 4.68 and a current ratio of 5.40.
About Pharming Group
(Get Rating)Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.
Recommended Stories
- Get a free copy of the StockNews.com research report on Pharming Group (PHAR)
- Power Integrations Stock Can Power Your Portfolio
- Don't Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe's?
- Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
- Three Penny Stocks Making Big Moves In November
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
Shares of Pharming Group (NASDAQ:PHAR – Get Rating) gapped up before the market opened on Monday . The stock had previously closed at $10.99, but opened at $11.35. Pharming Group shares last traded at $11.49, with a volume of 30 shares traded.
週一開盤前,製藥集團(納斯達克代碼:PharGet評級)的股價大幅上漲。該股此前收盤報10.99美元,開盤報11.35美元。輝瑞集團股票最新報11.49美元,總成交量為30股。
Analyst Ratings Changes
分析師評級發生變化
Separately, TheStreet raised shares of Pharming Group from a "d+" rating to a "c" rating in a research note on Monday, August 15th.
另外,華爾街在8月15日星期一的一份研究報告中將Pharming Group的股票評級從“d+”上調至“c”。
Pharming Group Stock Up 2.0 %
輝瑞集團股價上漲2.0%
The business's 50 day moving average price is $10.65 and its 200-day moving average price is $9.37. The firm has a market capitalization of $763.12 million, a PE ratio of 27.95 and a beta of -0.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 4.68 and a current ratio of 5.40.
該業務的50日移動均線價格為10.65美元,其200日移動均線價格為9.37美元。該公司市值為7.6312億美元,市盈率為27.95倍,貝塔係數為-0.30。該公司的負債權益比率為0.60,速動比率為4.68,流動比率為5.40。
About Pharming Group
關於Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.
生物製藥公司Pharing Group N.V.開發蛋白質替代療法和精準藥物並將其商業化,用於治療美國、歐洲和國際上未得到滿足的罕見疾病和醫療需求。該公司的主導產品是Ruconest,一種用於治療急性遺傳性血管性水腫的重組人C1酯酶抑制劑。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Pharming Group (PHAR)
- Power Integrations Stock Can Power Your Portfolio
- Don't Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe's?
- Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
- Three Penny Stocks Making Big Moves In November
- 免費獲取StockNews.com關於Pharming Group的研究報告(Phar)
- 電源整合股票可以為您的投資組合提供動力
- 不要追逐沃爾瑪更高,等待超低價格
- 家得寶的業績(和機構)是勞氏的催化劑嗎?
- 安捷倫在下週第四季度報告發布前仍在買入區間
- 三隻細價股在11月大動干戈
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受Pharming Group Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pharming Group和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧